Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies
about
Defining the Enterovirus Diversity Landscape of a Fecal Sample: A Methodological Challenge?Structure of Swine Vesicular Disease Virus: Mapping of Changes Occurring during Adaptation of Human Coxsackie B5 Virus To Infect SwineConformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron MicroscopyCryo-Electron Microscopy Reconstruction Shows Poliovirus 135S Particles Poised for Membrane Interaction and RNA ReleaseIdentification of enteroviruses by using monoclonal antibodies against a putative common epitope.Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein BAn externalized polypeptide partitions between two distinct sites on genome-released poliovirus particlesThe poliovirus 135S particle is infectious.Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease.Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing.Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution.Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus.Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humansIdentification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1Identification of T-helper epitopes in the VP1 capsid protein of poliovirus.Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regionsStructural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles.Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding siteUse of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14Three-dimensional structure of poliovirus serotype 1 neutralizing determinants.Regions of poliovirus protein VP1 produced in Escherichia coli induce neutralizing antibodies.A slender tract of glycine residues is required for translocation of the VP2 protein N-terminal domain through the parvovirus MVM capsid channel to initiate infection.The poliovirus empty capsid specifically recognizes the poliovirus receptor and undergoes some, but not all, of the transitions associated with cell entry.The N-terminal region of the VP1 protein of swine vesicular disease virus contains a neutralization site that arises upon cell attachment and is involved in viral entry.B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface.Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.Identification of group-common linear epitopes in structural and nonstructural proteins of enteroviruses by using synthetic peptides.Solid-phase synthesis of H-Phe-Tyr-(pATAT)-NH2: a nucleopeptide fragment from the nucleoprotein of bacteriophage phi X174.Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches.Peptide profiling of the route from Mahoney to Sabin, and return.
P2860
Q26771714-74021179-666F-44BA-81B4-8A209B373232Q27641911-09F22E8C-74D4-4243-98B8-11271AFEE0EFQ27678634-AE221099-5682-4AE1-A7B3-038A50EBFDADQ27680656-A768CF6C-BC96-4066-82E3-BBBC4B965B02Q31148699-4E9C6833-3AA4-43A2-A78A-D4E05236D211Q34256508-EEC094C9-79FA-4572-9B4D-41289F864E11Q35382676-A17DEFD1-E039-4E06-96D4-41F780C7AA8EQ35870848-B3526E81-3E2E-4D22-99FD-F47B2CD29C28Q35881226-CF39C251-11B1-43DE-9FD3-C5298B2D8264Q36245225-39E983AC-14B1-4D89-B4B5-0D21B2CC630CQ36281884-819FA6B0-B461-49FD-9875-B4058CF35771Q36633721-61B2703F-178C-413F-8D3B-269FF774528CQ36634400-439B2714-0608-4A49-BDA1-BAF3A9E5B373Q36642883-92036243-2DC8-4724-9474-9832EC8AAA9CQ36679977-E37D8468-9E0D-4B40-B288-6216922F2067Q36697502-AA9B3843-D853-4880-B0AE-52DE7B318121Q36702229-B3DF57C0-4AD5-4AC9-9566-33EBC1358E9CQ36796177-15D20F99-4AFA-4218-8E48-B6A27DCE33A6Q36805022-6DE3DCFE-294B-4349-B311-7FA34B327A43Q36833115-DAE55DF3-00B4-446B-8AD7-19F94FCD830AQ36855445-A342A9AD-B73A-42A1-BFAB-791CA60061FBQ36856186-DA5D76E6-0572-4D0C-8700-10703EDE8C0BQ36867416-E276D69A-34AF-45C5-9E71-0F2793B8FDB9Q36887417-E353DCF6-9D17-43CD-9FEE-896AE2BACE42Q39122157-748669F4-B1B5-481E-BF5E-047ECB3EEB86Q39580431-BAD66791-B6D7-4224-853A-179C0F67EF64Q39601668-766F3D27-D4BC-46BD-A6CC-BF0ACE64DDF5Q40043885-B8CFE1FD-6A95-45DF-B1A4-A2E37581B4F0Q40108230-40A3831F-3155-4C05-BAA6-CBA522AA34DFQ40178367-8B9541E3-B41C-40CD-B337-4CE8412D6E72Q40526055-302E6BEB-B025-4EEF-AB3B-33C4A45EEA3DQ45361083-470FD315-EF82-4E29-A3DF-5F778DC2EC6BQ51874169-24365105-8941-4B83-95F3-B6C6D6234709
P2860
Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synthetic peptides from four s ...... induce neutralizing antibodies
@en
Synthetic peptides from four s ...... nduce neutralizing antibodies.
@nl
type
label
Synthetic peptides from four s ...... induce neutralizing antibodies
@en
Synthetic peptides from four s ...... nduce neutralizing antibodies.
@nl
prefLabel
Synthetic peptides from four s ...... induce neutralizing antibodies
@en
Synthetic peptides from four s ...... nduce neutralizing antibodies.
@nl
P2093
P2860
P356
P1476
Synthetic peptides from four s ...... induce neutralizing antibodies
@en
P2093
P2860
P304
P356
10.1073/PNAS.82.3.910
P407
P577
1985-02-01T00:00:00Z